Cargando…

P843: METABOLOMIC CHARACTERIZATION OF HUMAN MULTIPLE MYELOMA CELL LINE TO STUDY TUMOR RESISTANCE TO DIFFERENT CLASSES OF THERAPEUTIC AGENTS

Detalles Bibliográficos
Autores principales: Steer, A., Chemlal, D., Varlet, E., Machura, A., Kassambara, A., Alaterre, E., Requirand, G., Robert, N., Hirtz, C., De Boussac, H., Bruyer, A., Moreaux, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430098/
http://dx.doi.org/10.1097/01.HS9.0000846256.48039.f8
_version_ 1784779656381071360
author Steer, A.
Chemlal, D.
Varlet, E.
Machura, A.
Kassambara, A.
Alaterre, E.
Requirand, G.
Robert, N.
Hirtz, C.
De Boussac, H.
Bruyer, A.
Moreaux, J.
author_facet Steer, A.
Chemlal, D.
Varlet, E.
Machura, A.
Kassambara, A.
Alaterre, E.
Requirand, G.
Robert, N.
Hirtz, C.
De Boussac, H.
Bruyer, A.
Moreaux, J.
author_sort Steer, A.
collection PubMed
description
format Online
Article
Text
id pubmed-9430098
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94300982022-08-31 P843: METABOLOMIC CHARACTERIZATION OF HUMAN MULTIPLE MYELOMA CELL LINE TO STUDY TUMOR RESISTANCE TO DIFFERENT CLASSES OF THERAPEUTIC AGENTS Steer, A. Chemlal, D. Varlet, E. Machura, A. Kassambara, A. Alaterre, E. Requirand, G. Robert, N. Hirtz, C. De Boussac, H. Bruyer, A. Moreaux, J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430098/ http://dx.doi.org/10.1097/01.HS9.0000846256.48039.f8 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Steer, A.
Chemlal, D.
Varlet, E.
Machura, A.
Kassambara, A.
Alaterre, E.
Requirand, G.
Robert, N.
Hirtz, C.
De Boussac, H.
Bruyer, A.
Moreaux, J.
P843: METABOLOMIC CHARACTERIZATION OF HUMAN MULTIPLE MYELOMA CELL LINE TO STUDY TUMOR RESISTANCE TO DIFFERENT CLASSES OF THERAPEUTIC AGENTS
title P843: METABOLOMIC CHARACTERIZATION OF HUMAN MULTIPLE MYELOMA CELL LINE TO STUDY TUMOR RESISTANCE TO DIFFERENT CLASSES OF THERAPEUTIC AGENTS
title_full P843: METABOLOMIC CHARACTERIZATION OF HUMAN MULTIPLE MYELOMA CELL LINE TO STUDY TUMOR RESISTANCE TO DIFFERENT CLASSES OF THERAPEUTIC AGENTS
title_fullStr P843: METABOLOMIC CHARACTERIZATION OF HUMAN MULTIPLE MYELOMA CELL LINE TO STUDY TUMOR RESISTANCE TO DIFFERENT CLASSES OF THERAPEUTIC AGENTS
title_full_unstemmed P843: METABOLOMIC CHARACTERIZATION OF HUMAN MULTIPLE MYELOMA CELL LINE TO STUDY TUMOR RESISTANCE TO DIFFERENT CLASSES OF THERAPEUTIC AGENTS
title_short P843: METABOLOMIC CHARACTERIZATION OF HUMAN MULTIPLE MYELOMA CELL LINE TO STUDY TUMOR RESISTANCE TO DIFFERENT CLASSES OF THERAPEUTIC AGENTS
title_sort p843: metabolomic characterization of human multiple myeloma cell line to study tumor resistance to different classes of therapeutic agents
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430098/
http://dx.doi.org/10.1097/01.HS9.0000846256.48039.f8
work_keys_str_mv AT steera p843metabolomiccharacterizationofhumanmultiplemyelomacelllinetostudytumorresistancetodifferentclassesoftherapeuticagents
AT chemlald p843metabolomiccharacterizationofhumanmultiplemyelomacelllinetostudytumorresistancetodifferentclassesoftherapeuticagents
AT varlete p843metabolomiccharacterizationofhumanmultiplemyelomacelllinetostudytumorresistancetodifferentclassesoftherapeuticagents
AT machuraa p843metabolomiccharacterizationofhumanmultiplemyelomacelllinetostudytumorresistancetodifferentclassesoftherapeuticagents
AT kassambaraa p843metabolomiccharacterizationofhumanmultiplemyelomacelllinetostudytumorresistancetodifferentclassesoftherapeuticagents
AT alaterree p843metabolomiccharacterizationofhumanmultiplemyelomacelllinetostudytumorresistancetodifferentclassesoftherapeuticagents
AT requirandg p843metabolomiccharacterizationofhumanmultiplemyelomacelllinetostudytumorresistancetodifferentclassesoftherapeuticagents
AT robertn p843metabolomiccharacterizationofhumanmultiplemyelomacelllinetostudytumorresistancetodifferentclassesoftherapeuticagents
AT hirtzc p843metabolomiccharacterizationofhumanmultiplemyelomacelllinetostudytumorresistancetodifferentclassesoftherapeuticagents
AT deboussach p843metabolomiccharacterizationofhumanmultiplemyelomacelllinetostudytumorresistancetodifferentclassesoftherapeuticagents
AT bruyera p843metabolomiccharacterizationofhumanmultiplemyelomacelllinetostudytumorresistancetodifferentclassesoftherapeuticagents
AT moreauxj p843metabolomiccharacterizationofhumanmultiplemyelomacelllinetostudytumorresistancetodifferentclassesoftherapeuticagents